Enzyme Gain-of-Function

Most enzyme defects cause disease by loss of activity, but a minority do so through gain of function, in which a mutation increases, constitutively activates, or otherwise abnormally enhances an enzyme's activity. Such variants often produce dominantly inherited disease and act by mechanisms structurally distinct from loss-of-function mutations.

Definition

An enzyme gain-of-function mutation is a sequence variant that increases or constitutively activates the catalytic or signalling activity of an enzyme (or enzyme-coupled protein), producing disease through excess rather than deficient activity.

Scope

This topic covers the concept of gain-of-function in enzymes and enzyme-coupled signalling proteins: how activating mutations arise, how they differ structurally and genetically from loss-of-function variants, and illustrative examples such as the activating G-protein mutation of McCune-Albright syndrome. It is framed mechanistically and does not give clinical management guidance.

Core questions

• How can a mutation increase rather than decrease enzyme activity?
• Why are gain-of-function variants often dominant?
• How do gain-of-function and dominant-negative mutations differ structurally from loss-of-function ones?
• What distinguishes a true catalytic gain of function from constitutive activation of a signalling enzyme?

Key concepts

• Activating mutation
• Constitutive activation
• Dominant inheritance
• Dominant-negative versus gain-of-function
• Signalling enzymes (e.g., G proteins)
• Structural mildness of non-loss-of-function variants
• Excess activity as a disease mechanism

Mechanisms

A gain-of-function mutation can lock an enzyme in an active conformation, remove normal regulatory control, or increase its intrinsic catalytic rate, so that activity is inappropriately high or no longer responsive to signals. In enzyme-coupled signalling, an activating mutation in the stimulatory G protein constitutively raises downstream activity, as in McCune-Albright syndrome. Structural analyses show that gain-of-function and dominant-negative variants typically perturb protein structure less severely than loss-of-function variants, consistent with their producing an altered or excessive activity rather than simply destroying the protein; such mutations are often dominant because a single altered allele suffices to cause the abnormal activity.

Clinical relevance

Recognising that some disorders stem from too much rather than too little enzyme activity changes how their mechanism and inheritance are understood and is relevant to interpreting dominantly inherited conditions. This entry is educational reference material and does not provide diagnostic criteria or treatment advice.

History

The loss-of-function view dominated early thinking about enzyme defects, following Garrod's recessive model. The identification of activating mutations, such as the constitutively active stimulatory G protein in McCune-Albright syndrome reported in 1991, established gain-of-function as a distinct disease mechanism, and later structural and computational analyses clarified how it differs from loss-of-function and dominant-negative effects.

Debates

How should gain-of-function be distinguished from dominant-negative mechanisms?

Both can produce dominant disease and both differ structurally from loss-of-function, but they act differently, one by adding abnormal activity and the other by interfering with the normal protein; distinguishing them from sequence and structure alone remains challenging.

Key figures

• Allen Spiegel
• Lee Weinstein
• Joseph Marsh
• Stylianos Antonarakis

Seminal works

• weinstein-1991
• gerasimavicius-2022
• backwell-2022

Frequently asked questions

Can a mutation make an enzyme too active instead of inactive?

Yes; activating or gain-of-function mutations can lock an enzyme in an active state, remove its normal regulation, or speed its catalysis, causing disease through excess activity.

Why are gain-of-function enzyme disorders often dominant?

Because a single mutant allele can produce the abnormal extra activity, one affected copy is usually enough to cause disease, giving a dominant pattern of inheritance.